Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome

@article{Celiberto2018InflammatoryBD,
  title={Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome},
  author={L. S. Celiberto and F. A. Graef and G. Healey and E. Bosman and K. Jacobson and L. Sly and B. Vallance},
  journal={Immunology},
  year={2018},
  volume={155}
}
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, thought to at least in part reflect an aberrant immune response to gut bacteria. IBD is increasing in incidence, particularly in populations that have recently immigrated to western countries. This suggests that environmental factors are involved in its pathogenesis. We hypothesize that the increase in IBD rates might reflect the consumption of an unhealthy Western diet, containing excess… Expand

Paper Mentions

Interventional Clinical Trial
Time-restricted feeding (TRF) is a dietary regimen involving the consumption of food and liquids within a defined time window with or without additional restriction on dietary… Expand
ConditionsCrohn's Disease (CD)
InterventionOther
Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
TLDR
Pediatric IBD specific studies that focus on the benefits of fiber and prebiotics on gut microbiome composition and functional capacity and disease outcomes are required. Expand
Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
TLDR
The health and disease IBD-associated microbiota patterns will be discussed, in addition to the effect of currently used therapies for IBD on the gut microbiota composition, as well as new therapeutic approaches that can be used to overcome the current treatment constraints. Expand
Gut microbiota and inflammatory bowel disease: The current status and perspectives
TLDR
The effect of the gut microbiome in treating patients with IBD is discussed and the possible curative effect of microbiome-modulating interventions are discussed. Expand
The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review
TLDR
The mechanisms of diet–microbial–immune system interaction are summarized, key studies examining associations between diet and IBD and evidence demonstrating the impact of diet on disease control are outlined. Expand
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease
TLDR
The therapeutic potential of SCFA and Trp post-biotics on IBD is discussed through approaches based on the “immunonutrition,” defined as a modulation of the immune system provided by specific interventions that modify dietary nutrients. Expand
The role of the gut microbiota in the treatment of inflammatory bowel diseases.
TLDR
The recent findings on the association of dysbiosis with IBD pathogenesis are presented, the role of gut microbiota on the treatment of IBD is focused on and the novel and currently available therapeutic strategies in manipulating the composition and function of Gut microbiota in IBD patients are discussed. Expand
Vitamin D and GUT Microbiota: A Review
TLDR
This study aimed to review the relationship between vitamin D and gut microbiota and found some of theanti-inflammatory effects of vitamin D may be related to the changes in the composition of the intestinal microbiota. Expand
Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease.
TLDR
There is an important need for rigorous studies robustly informing the association and mechanism(s) of influence of the external environment on IBD risk and for clinical trials examining the efficacy of alteration of the environment in ameliorating the course of IBD. Expand
Gut Microbiome and Osteoporosis
TLDR
The molecular mechanisms underlying the regulatory effect of gut microbes on osteoporosis and the clinical practice of using gut microbes to improve bone health are reviewed. Expand
Anthocyanins in chronic inflammatory bowel disease in rats
TLDR
It is concluded that functional foods containing anthocyanins may be an alternate or complementary treatment for IBD patients owing to their anti-inflammatory activity, and the ability to balance gut bacteria. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 221 REFERENCES
The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces
TLDR
A comprehensive review on the impact of westernized diet and associated nutrients on immune cell responses and the microbiota and how these can influence the pathology of IBD and asthma is provided. Expand
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease
TLDR
The contribution of host genetics and diet in altering gut microbiome, and in turn, the crosstalk among secondary metabolic pathways, are highlighted, paying special emphasis on physiologically inter-related processes. Expand
Diet and nutritional factors in inflammatory bowel diseases.
TLDR
There is no single common diet suitable for all IBD patients; each of them is unique and dietary recommendations must be individually developed for each patient, depending on the course of the disease, past surgical procedures and type of pharmacotherapy. Expand
A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.
TLDR
Oral intake of a specific multi fibre mix (MF), designed to match the fibre content of a healthy diet, counteracts IBD-like intestinal inflammation and weight loss in dextran sodium sulphate treated mice. Expand
Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease
TLDR
Clearly, some probiotics have considerable potential in the management of IBS and IBD; however, the benefits are strain specific and recommendations should be made for specific strains and for specific symptoms. Expand
Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome.
TLDR
Several important pathways, such as nucleotide-binding oligomerization domain-like receptor, affected by VDR status are identified, including amino acid, carbohydrate, and fatty acid synthesis and metabolism, detoxification, infections, signal transduction, and cancer and other diseases. Expand
Immunoregulation of Inflammatory and Inhibitory Cytokines by Vitamin D3 in Patients with Inflammatory Bowel Diseases
TLDR
The results of the accumulated bodies of research demonstrate that vitamin D3 plays a major role not only in the immunoregulation of cytokines involved in the pathogenesis of IBDs but also in many other inflammatory disorders. Expand
Metabolic Inflammation-Differential Modulation by Dietary Constituents
TLDR
Therapeutics, lifestyle changes, supplements and dietary manipulation are all possible avenues to combat metabolic inflammation and the subsequent insulin resistant state which will be explored in the current review. Expand
Immunologic impact of the intestine in metabolic disease
TLDR
It is proposed that an understanding of the changes to the intestinal immune system, and how these changes influence systemic immunity and glucose metabolism in a whole-body integrative and a neuronal-dependent network, will unveil novel intestinal pathologic and therapeutic targets for diabetes and obesity. Expand
Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome
TLDR
It is proposed that the functional composition of the gut microbiome may provide a more consistent definition of dysbiosis and may more readily provide evidence of genome–microbiome interactions in future exploratory studies. Expand
...
1
2
3
4
5
...